Webinar | July 14, 2025

3:00 p.m. – 4:00 p.m. ET

Register here.

Insurance companies have been busily accessing the capital markets in 2024 and in 2025 with traditional debt offerings, as well as with hybrid capital and structured solutions, including P-CAPs and funding-agreement backed notes (FABNs) transactions. In fact, the volume of FABN issuance is on track to outpace that of the last few years.  Insurance companies must take into account legal and regulatory considerations in evaluating their funding and capital-raising alternatives. During this session hosted by PLI, we will consider these as we discuss the following:

  • Short-term funding, including commercial paper;
  • Term funding, including senior and subordinated debt;
  • P-CAPs and why an insurance company would choose to rely on contingent funding alternatives;
  • Surplus notes and the distinct regulatory considerations;
  • FABNs as well as funding agreement backed repo; and
  • Securities offering methodologies.